| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b3c2e77f8dfda692ca527454d23ecc03
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_eb9c6b40161bafe7bd55f0b4defcea04 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2300-00 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-58
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-551
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4439
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-444
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-496
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-427
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-5517 |
| filingDate |
2015-11-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9ec8cc374890e91ee755cd848c961ff0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_96bef5fd5b06f81364a9f92be0c3b5f0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4c787691bf020a63ca451e6a749e4f71
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_275c3cbe7fa69410491df2018b8e0791 |
| publicationDate |
2017-10-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
CN-107249593-A |
| titleOfInvention |
Adjusting the composition of chromatin Structure is used for the purposes of graft versus host disease (GVHD) |
| abstract |
The present invention is related to the method for the treatment of chronic graft versus host disease (cGVHD) in certain aspects.In some embodiments, this method includes snibject EZH2 inhibitor, Bcl6 inhibitor and/or the BRD4 inhibitor to needs.It is of the invention to be at least partly based on the discovery that zeste enhancers homologue 2 (EZH2) inhibitor, the albumen of B cell lymphomas 6 (Bcl6) inhibitor and/or brominated domain protein 4 (BRD4) inhibitor can be used for treatment chronic graft versus host disease (cGVHD). |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-108685880-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-112341390-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-112341390-B |
| priorityDate |
2014-11-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |